0
0
0
0
1
2
3
$0
Is Steris solid or fragile? The Finex Financial Health Scanner reads STE's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $5.9B |
|---|---|
| Net income | $782.3M |
| Operating margin | 18.6% |
| Net margin | 13.2% |
| Cash and investments | $439.6M |
| Total debt | $1.9B |
| Free cash flow | $822.3M |
| Revenue growth (1 year) | 8.7% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.